Global prevalence of chronic migraine: A systematic review

J. L. Natoli; A. Manack; B. Dean; Q. Butler; C. C. Turkel; L. Stovner; R. B. Lipton

doi:10.1111/j.1468-2982.2009.01941.x

Global prevalence of chronic migraine: A systematic review

J. L. Natoli, A. Manack, B. Dean, Q. Butler, C. C. Turkel, L. Stovner, R. B. Lipton

Neurology

Research output: Contribution to journal › Review article › peer-review

502 Scopus citations

Abstract

The aim of this review was to summarize population-based studies reporting prevalence and/or incidence of chronic migraine (CM) and to explore variation across studies. A systematic literature search was conducted. Relevant data were abstracted and estimates were subdivided based on the criteria used in each study. Sixteen publications representing 12 studies were accepted. None presented data on CM incidence. The prevalence of CM was 0-5.1%, with estimates typically in the range of 1.4-2.2%. Seven studies used Silberstein-Lipton criteria (or equivalent), with prevalence ranging from 0.9% to 5.1%. Three estimates used migraine that occurred ≥ 15 days per month, with prevalence ranging from 0 to 0.7%. Prevalence varied by World Health Organization region and gender. This review identified population-based studies of CM prevalence, although heterogeneity across studies and lack of data from certain regions leaves an incomplete picture. Future studies on CM would benefit from an International Classification of Headache Disorders consensus diagnosis that is clinically appropriate and operational in epidemiological studies.

Original language	English (US)
Pages (from-to)	599-609
Number of pages	11
Journal	Cephalalgia
Volume	30
Issue number	5
DOIs	https://doi.org/10.1111/j.1468-2982.2009.01941.x
State	Published - May 2010

Keywords

Chronic migraine
Epidemiology
Prevalence
Systematic review

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1111/j.1468-2982.2009.01941.x

Cite this

@article{168286548edd4a3fa1f224912db4de55,

title = "Global prevalence of chronic migraine: A systematic review",

abstract = "The aim of this review was to summarize population-based studies reporting prevalence and/or incidence of chronic migraine (CM) and to explore variation across studies. A systematic literature search was conducted. Relevant data were abstracted and estimates were subdivided based on the criteria used in each study. Sixteen publications representing 12 studies were accepted. None presented data on CM incidence. The prevalence of CM was 0-5.1%, with estimates typically in the range of 1.4-2.2%. Seven studies used Silberstein-Lipton criteria (or equivalent), with prevalence ranging from 0.9% to 5.1%. Three estimates used migraine that occurred ≥ 15 days per month, with prevalence ranging from 0 to 0.7%. Prevalence varied by World Health Organization region and gender. This review identified population-based studies of CM prevalence, although heterogeneity across studies and lack of data from certain regions leaves an incomplete picture. Future studies on CM would benefit from an International Classification of Headache Disorders consensus diagnosis that is clinically appropriate and operational in epidemiological studies.",

keywords = "Chronic migraine, Epidemiology, Prevalence, Systematic review",

author = "Natoli, {J. L.} and A. Manack and B. Dean and Q. Butler and Turkel, {C. C.} and L. Stovner and Lipton, {R. B.}",

note = "Funding Information: The authors thank Nirav Shah, MD, MPH, for his valuable feedback on this manuscript. The research presented in this paper was supported by Allergan, Inc. Employees for Allergan, Inc. were involved in the methodological design of the systematic literature review and helped write and edit drafts of this manuscript. They were not primarily involved in decisions regarding the included literature, management, analysis, or interpretation of the data. Primary decisions regarding the collection, management, analysis, and interpretation of the data were made by consultants. Copyright: Copyright 2011 Elsevier B.V., All rights reserved.",

year = "2010",

month = may,

doi = "10.1111/j.1468-2982.2009.01941.x",

language = "English (US)",

volume = "30",

pages = "599--609",

journal = "Cephalalgia",

issn = "0333-1024",

publisher = "SAGE Publications Ltd",

number = "5",

}

TY - JOUR

T1 - Global prevalence of chronic migraine

T2 - A systematic review

AU - Natoli, J. L.

AU - Manack, A.

AU - Dean, B.

AU - Butler, Q.

AU - Turkel, C. C.

AU - Stovner, L.

AU - Lipton, R. B.

N1 - Funding Information: The authors thank Nirav Shah, MD, MPH, for his valuable feedback on this manuscript. The research presented in this paper was supported by Allergan, Inc. Employees for Allergan, Inc. were involved in the methodological design of the systematic literature review and helped write and edit drafts of this manuscript. They were not primarily involved in decisions regarding the included literature, management, analysis, or interpretation of the data. Primary decisions regarding the collection, management, analysis, and interpretation of the data were made by consultants. Copyright: Copyright 2011 Elsevier B.V., All rights reserved.

PY - 2010/5

Y1 - 2010/5

N2 - The aim of this review was to summarize population-based studies reporting prevalence and/or incidence of chronic migraine (CM) and to explore variation across studies. A systematic literature search was conducted. Relevant data were abstracted and estimates were subdivided based on the criteria used in each study. Sixteen publications representing 12 studies were accepted. None presented data on CM incidence. The prevalence of CM was 0-5.1%, with estimates typically in the range of 1.4-2.2%. Seven studies used Silberstein-Lipton criteria (or equivalent), with prevalence ranging from 0.9% to 5.1%. Three estimates used migraine that occurred ≥ 15 days per month, with prevalence ranging from 0 to 0.7%. Prevalence varied by World Health Organization region and gender. This review identified population-based studies of CM prevalence, although heterogeneity across studies and lack of data from certain regions leaves an incomplete picture. Future studies on CM would benefit from an International Classification of Headache Disorders consensus diagnosis that is clinically appropriate and operational in epidemiological studies.

AB - The aim of this review was to summarize population-based studies reporting prevalence and/or incidence of chronic migraine (CM) and to explore variation across studies. A systematic literature search was conducted. Relevant data were abstracted and estimates were subdivided based on the criteria used in each study. Sixteen publications representing 12 studies were accepted. None presented data on CM incidence. The prevalence of CM was 0-5.1%, with estimates typically in the range of 1.4-2.2%. Seven studies used Silberstein-Lipton criteria (or equivalent), with prevalence ranging from 0.9% to 5.1%. Three estimates used migraine that occurred ≥ 15 days per month, with prevalence ranging from 0 to 0.7%. Prevalence varied by World Health Organization region and gender. This review identified population-based studies of CM prevalence, although heterogeneity across studies and lack of data from certain regions leaves an incomplete picture. Future studies on CM would benefit from an International Classification of Headache Disorders consensus diagnosis that is clinically appropriate and operational in epidemiological studies.

KW - Chronic migraine

KW - Epidemiology

KW - Prevalence

KW - Systematic review

UR - http://www.scopus.com/inward/record.url?scp=77954762392&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954762392&partnerID=8YFLogxK

U2 - 10.1111/j.1468-2982.2009.01941.x

DO - 10.1111/j.1468-2982.2009.01941.x

M3 - Review article

C2 - 19614702

AN - SCOPUS:77954762392

SN - 0333-1024

VL - 30

SP - 599

EP - 609

JO - Cephalalgia

JF - Cephalalgia

IS - 5

ER -

Global prevalence of chronic migraine: A systematic review

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this